Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oncobox Bioinformatical Platform for Selecting Potentially Effective Combinations of Target Cancer Drugs Using High-Throughput Gene Expression Data.
Sorokin M, Kholodenko R, Suntsova M, Malakhova G, Garazha A, Kholodenko I, Poddubskaya E, Lantsov D, Stilidi I, Arhiri P, Osipov A, Buzdin A. Sorokin M, et al. Among authors: poddubskaya e. Cancers (Basel). 2018 Sep 29;10(10):365. doi: 10.3390/cancers10100365. Cancers (Basel). 2018. PMID: 30274248 Free PMC article.
First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817.
Ready NE, Audigier-Valette C, Goldman JW, Felip E, Ciuleanu TE, Rosario García Campelo M, Jao K, Barlesi F, Bordenave S, Rijavec E, Urban L, Aucoin JS, Zannori C, Vermaelen K, Arén Frontera O, Curioni Fontecedro A, Sánchez-Gastaldo A, Juan-Vidal O, Linardou H, Poddubskaya E, Spigel DR, Ahmed S, Maio M, Li S, Chang H, Fiore J, Acevedo A, Paz-Ares L. Ready NE, et al. Among authors: poddubskaya e. J Immunother Cancer. 2023 Feb;11(2):e006127. doi: 10.1136/jitc-2022-006127. J Immunother Cancer. 2023. PMID: 36725084 Free PMC article. Clinical Trial.
Acquired resistance to tyrosine kinase inhibitors may be linked with the decreased sensitivity to X-ray irradiation.
Sorokin M, Kholodenko R, Grekhova A, Suntsova M, Pustovalova M, Vorobyeva N, Kholodenko I, Malakhova G, Garazha A, Nedoluzhko A, Vasilov R, Poddubskaya E, Kovalchuk O, Adamyan L, Prassolov V, Allina D, Kuzmin D, Ignatev K, Osipov A, Buzdin A. Sorokin M, et al. Among authors: poddubskaya e. Oncotarget. 2017 Dec 27;9(4):5111-5124. doi: 10.18632/oncotarget.23700. eCollection 2018 Jan 12. Oncotarget. 2017. PMID: 29435166 Free PMC article.
RNA sequencing for research and diagnostics in clinical oncology.
Buzdin A, Sorokin M, Garazha A, Glusker A, Aleshin A, Poddubskaya E, Sekacheva M, Kim E, Gaifullin N, Giese A, Seryakov A, Rumiantsev P, Moshkovskii S, Moiseev A. Buzdin A, et al. Among authors: poddubskaya e. Semin Cancer Biol. 2020 Feb;60:311-323. doi: 10.1016/j.semcancer.2019.07.010. Epub 2019 Aug 11. Semin Cancer Biol. 2020. PMID: 31412295 Review.
RNA sequencing profiles and diagnostic signatures linked with response to ramucirumab in gastric cancer.
Sorokin M, Poddubskaya E, Baranova M, Glusker A, Kogoniya L, Markarova E, Allina D, Suntsova M, Tkachev V, Garazha A, Sekacheva M, Buzdin A. Sorokin M, et al. Among authors: poddubskaya e. Cold Spring Harb Mol Case Stud. 2020 Apr 1;6(2):a004945. doi: 10.1101/mcs.a004945. Print 2020 Apr. Cold Spring Harb Mol Case Stud. 2020. PMID: 32060041 Free PMC article.
Disparity between Inter-Patient Molecular Heterogeneity and Repertoires of Target Drugs Used for Different Types of Cancer in Clinical Oncology.
Zolotovskaia MA, Sorokin MI, Petrov IV, Poddubskaya EV, Moiseev AA, Sekacheva MI, Borisov NM, Tkachev VS, Garazha AV, Kaprin AD, Shegay PV, Giese A, Kim E, Roumiantsev SA, Buzdin AA. Zolotovskaia MA, et al. Among authors: poddubskaya ev. Int J Mol Sci. 2020 Feb 26;21(5):1580. doi: 10.3390/ijms21051580. Int J Mol Sci. 2020. PMID: 32111026 Free PMC article.
51 results